Navigation Links
Sanofi-aventis Announces Good First-quarter 2009 Performance
Date:4/29/2009

bdominal surgery; -- the intradermal influenza vaccine Intanza(R) in Europe, and the pandemic influenza vaccine Emerflu(R) in Australia.

Acquisitions

During the first quarter of 2009, sanofi-aventis completed the offer on Zentiva, which will provide a platform for growth in branded generics in Central and Eastern Europe, Turkey, and Russia. Zentiva is fully consolidated by sanofi-aventis from March 31, 2009.

In addition to Zentiva, the generics business has been further strengthened in April 2009 by the completion of the acquisitions of Kendrick (one of Mexico's leading generics manufacturers) and Medley (Brazil's third-largest pharmaceutical company and no.1 generics manufacturer).

On a 2008 proforma basis, these three acquisitions take net sales from generics to approximately euro 1.2 billion, compared with euro 349 million in 2008. These deals are in line with the strategy of reinforcing our presence in branded generics and expanding our product portfolio in emerging markets, which are characterized by strong growth, low or average disposable incomes, and competitively-priced pharmaceutical products.

Sanofi-aventis has recently acquired BiPar Sciences, Inc., a privately held U.S. biopharmaceutical company which is developing novel tumor-selective approaches for the treatment of different types of cancers. Under the terms of the agreement, the purchase consideration will be contingent on milestone payments linked to the development of BSI-201, but will not exceed $500 million.

Net debt

Sanofi-aventis generated a high level of cash flow from operations in the first quarter of 2009 (euro 2,755 million), more than adequate to finance capital expenditure of euro 392 million and acquisitions of euro 1,851 million (mainly Zentiva, including net debt of euro 551 million). Free cash flow for the quarter was
'/>"/>

SOURCE Sanofi-aventis
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related medicine news :

1. Sanofi-Aventis and Roche/Chugais Drugs Will Dominate the Indian Colorectal Cancer Drug Market Through 2013
2. Sanofi-aventis Affirms Its Commitment to Partnering with Local Communities to Improve Hispanic and African American Health
3. Apidra(R) SoloSTAR(R), the Easy-to-Use Insulin Delivery Device from sanofi-aventis, Now Available in the United States
4. Paul Chew Appointed to sanofi-aventis U.S. Chief Science Officer/Chief Medical Officer
5. Sanofi-aventis Partners with the Hispanic Community in Miami to Increase Health Awareness, Access to Resources and Help Improve Patient Care
6. Sanofi-aventis Partners with the Hispanic Community in San Antonio to Increase Health Awareness, Access to Resources and Help Improve Patient Care
7. Sanofi-aventis Delivers 2008 Results Above Guidance
8. Sanofi-aventis Partners with the Hispanic Community in Bronx to Increase Health Awareness, Access to Resources and Help Improve Patient Care
9. Sanofi-aventis Partners with the African American Community in Memphis to Increase Health Awareness, Access to Resources and Help Improve Patient Care
10. Sanofi-aventis U.S. Announces Increased Access to Drugs for Low Income Patients Through Expanded PAP Programs
11. Sanofi-aventis Partners with the African American Community in Baltimore to Increase Health Awareness, Access to Resources and Help Improve Patient Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2014)... The report, “Glass Fiber & Glass ... Material, By Manufacturing Process, By Application (Transportation, Construction, ... – Global Trends & Forecast to 2019”, defines ... an analysis and forecast by value and volume. ... figures spread through 347 slides and in-depth TOC ...
(Date:7/27/2014)... July 27, 2014 The constant expansion ... increase in demand for enterprise video. Additional factors that ... video in areas such as corporate communication, learning and ... Due to all these factors the enterprise video market ... expected to reach $35.57 billion in 2018 with a ...
(Date:7/27/2014)... 2014 This is a professional ... Dutasteride (CAS 164656-23-9) industry. The report firstly reviews ... its classification, application and manufacturing technology. The report ... Dutasteride (CAS 164656-23-9) listing their product specification, capacity, ... report further analyzes quantitatively 2009-2014 global and China’s ...
(Date:7/27/2014)... 27, 2014 1-Butene is a colorless, ... solvent properties. 1–Butene can be manufactured either through the ... reaction of ethylene. Linear alpha olefin (alkene) 1-Butene is ... a number of important chemicals such as linear light ... on. , The 1-Butene market is extremely competitive. The ...
(Date:7/27/2014)... York, NY (PRWEB) July 27, 2014 ... involving liver injuries continue to move forward in ... new study is questioning one of the benefits ... Tylenol-brand over-the-counter medications. The research, which appears in ... acute low-back pain, all of whom were given ...
Breaking Medicine News(10 mins):Health News:Major Drivers for GFRP Composites Market in Future – Report by MarketsandMarkets 2Health News:Major Drivers for GFRP Composites Market in Future – Report by MarketsandMarkets 3Health News:Major Drivers for GFRP Composites Market in Future – Report by MarketsandMarkets 4Health News:North America Enterprise Video Market is Expected to Reach $13.00 billion in 2018 - New Report by MicroMarket Monitor 2Health News:North America Enterprise Video Market is Expected to Reach $13.00 billion in 2018 - New Report by MicroMarket Monitor 3Health News:North America Enterprise Video Market is Expected to Reach $13.00 billion in 2018 - New Report by MicroMarket Monitor 4Health News:Global and Chinese Dutasteride Industry (CAS 164656-23-9) 2019 Forecasts in New Research Report at ReportsnReports.com 2Health News:Global and Chinese Dutasteride Industry (CAS 164656-23-9) 2019 Forecasts in New Research Report at ReportsnReports.com 3Health News:Global and Chinese Dutasteride Industry (CAS 164656-23-9) 2019 Forecasts in New Research Report at ReportsnReports.com 4Health News:North America 1-Butene Market is Expected to Reach $794 million in 2018 - New Report by MicroMarket Monitor 2Health News:North America 1-Butene Market is Expected to Reach $794 million in 2018 - New Report by MicroMarket Monitor 3Health News:North America 1-Butene Market is Expected to Reach $794 million in 2018 - New Report by MicroMarket Monitor 4Health News:As Tylenol Lawsuits Mount, Bernstein Liebhard LLP Notes Study Questioning Some Benefits Purportedly Associated with Acetaminophen 2Health News:As Tylenol Lawsuits Mount, Bernstein Liebhard LLP Notes Study Questioning Some Benefits Purportedly Associated with Acetaminophen 3Health News:As Tylenol Lawsuits Mount, Bernstein Liebhard LLP Notes Study Questioning Some Benefits Purportedly Associated with Acetaminophen 4
... allows longer filtering, which experts prefer , , THURSDAY, May ... are asleep, not only frees up time during their ... well, a new study suggests. , Although lifesaving, dialysis ... it. Nighttime dialysis, a newer option, actually takes longer ...
... Cambridge, MA May, 21, 2009 Agios Pharmaceuticals, ... novel cancer metabolism drugs, announced that the leading scientific ... "Understanding the Warburg Effect: The Metabolic Requirements of ... C. Cantley, Ph.D., Director of the Cancer Center at ...
... Military ProgramSHORT HILLS, N.J., May 21 The ... organization dedicated to finding cures and treatments for ... people living with paralysis, announced today it has ... charitable giving arm, the TD Charitable Foundation. ...
... Transportation as Legislative Priority for 2009WASHINGTON, May 21 ... the federal transportation bill this year, the American ... for America coalition in releasing a blueprint to ... Route to Reform," outlines a renewed vision for ...
... (Princeton, New Jersey) Lingraphica, maker of the Lingraphica speech-generating ... mobile accessory. Incredibly portable and light, it fits easily ... on the go. Users can take along a selection ... at all times. Together, the Lingraphica speech-generating device and ...
... Department of Veterans Affairs (VA) has provided $215 million ... Veterans in rural and highly rural areas. "This ... health care needs of our rural Veterans," Secretary of ... allow VA to establish new outpatient clinics, expand collaborations ...
Cached Medicine News:Health News:Sleeping Through Dialysis May Be the Way to Go 2Health News:Sleeping Through Dialysis May Be the Way to Go 3Health News:Agios Pharmaceuticals' founders author Science review on cancer metabolism 2Health News:Christopher & Dana Reeve Foundation Receives $25,000 Gift from TD Bank 2Health News:Christopher & Dana Reeve Foundation Receives $25,000 Gift from TD Bank 3Health News:APHA Joins National Coalition in Issuing Transportation Reform Blueprint 2Health News:Secretary Shinseki Announces $215 Million in Projects for Rural Veterans 2
(Date:7/25/2014)... /PRNewswire-iReach/ -- Dr. Michael Gabriel of a prominent ... a recent study, which shows how grief in pregnancy may ... According to US News , ... likely than others to grow up overweight or obese, even ... were two specific types of stress that caused obesity: "Children ...
(Date:7/24/2014)... PLAINFIELD, N.J. , July 24, 2014  PTC ... that the Company will host a webcast conference call ... provide an update on the company,s business and outlook ... before the opening of the market. ... (domestic) or (973) 935-8152 (international) five minutes prior to ...
(Date:7/24/2014)... Germany , and MARSEILLE, France ... , Exclusive global license from University of ... including next-generation sequencing (NGS) gene panels, for blood cancers  ... by new test, indicate favorable prognosis for patients with ... QIAGEN sees potential for developing companion diagnostics to guide ...
Breaking Medicine Technology:Dr. Michael Gabriel of GPM Pediatrics, a Noted Staten Island Pediatrics Clinic, Comments on Study, Which Names Grief as a Cause of Obesity in Children 2QIAGEN Adds Promising Genomic Biomarkers for Assessing Prognosis in Treatment of Blood Cancers to Personalized Healthcare Pipeline 2QIAGEN Adds Promising Genomic Biomarkers for Assessing Prognosis in Treatment of Blood Cancers to Personalized Healthcare Pipeline 3QIAGEN Adds Promising Genomic Biomarkers for Assessing Prognosis in Treatment of Blood Cancers to Personalized Healthcare Pipeline 4QIAGEN Adds Promising Genomic Biomarkers for Assessing Prognosis in Treatment of Blood Cancers to Personalized Healthcare Pipeline 5
... Oct. 28 IRIDEX Corporation (Nasdaq: IRIX ) today ... after the market closes on Thursday, November 4, 2010. ... a conference call with the investment community at 5:00 ... 2010 to discuss the results of the quarter and ...
... SAN DIEGO, Oct. 28 ASTRO Booth # 201 ... will highlight its new TrueBeam™ system for fast, powerful and ... American Society for Radiation Oncology (ASTRO) meeting in San Diego ... as new software capabilities designed to make cancer treatments faster, ...
Cached Medicine Technology:Varian Medical Systems to Exhibit TrueBeam™ System for Image-Guided Cancer Treatments and New Software Capabilities at ASTRO Meeting in San Diego 2Varian Medical Systems to Exhibit TrueBeam™ System for Image-Guided Cancer Treatments and New Software Capabilities at ASTRO Meeting in San Diego 3
Irrigating Cystotome, Straight, 25 g. Overall length 15 mm. 5/box....
Irrigating Capsulorhexis Cystotome. Formed blunt tip, 25 g. Overall length 22 mm. 5/box....
Irrigating Cystotome, formed, 23 g., 12 mm curved tip. Overall length 14 mm. 5/box....
Retrobulbar Needle, 25 g. Atkinson style bevel. Overall length 38 mm. 5/box....
Medicine Products: